UAE IVF DRUGS AND FOOD SUPPLEMENTS MARKET ANALYSIS

Market Challenges And Opportunities

• High cost of treatment

Market players are indulged in inorganic activities such as partnership, acquisition, and collaboration, which is expected to drive the market growth during the forecast period.

Market players are indulged in inorganic activities such as partnership, acquisition and collaboration, which is expected to propel growth of the UAE IVF drugs and food supplements market during the forecast period. For instance, on March 29, 2019, Boston IVF, an infertility treatment service provider and Ohio Reproductive Medicine, an infertility center, announced new partnership. Moreover, the aim of this partnership is to advance the Ohio Reproductive Medicine’s mission to deliver world-class fertility treatments and care, including in vitro fertilization (IVF), genetic testing, male factor, LGBTQ+ family building, egg freezing, and others. With technology and research playing an increasingly critical role in the quality of patient care, future initiatives will include opportunities for ORM to benefit from Boston IVF’s innovative science that improves IVF outcomes and lessens time in treatment at global level which is expected to cover the UAE IVF drugs and food supplements market owing to the research and development for fertility issues in upcoming years.

UAE IVF Drugs and Food Supplements Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper growth of the UAE IVF drugs and food supplements market during the forecast period. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 340 million cases and 5,570,163 deaths due to coronavirus disease (COVID-19) were reported up till January 23, 2022, across the global.

Furthermore, many hospitals maximize wellbeing of patients, staff, and society at large. There is a confusing picture of the effect of COVID-19 on fertility treatments, with the advice and guidance coming from several different resources such as ASRM (American Society of Reproductive Medicine) stated that in year 2020 some women have postponed their IVF consultations, whereas others have delayed their dates of embryo transfer until the pandemic situation ends and life comes back to normal. According to The U.S.-U.A.E. Business Council In the midst of this public health crisis, the healthcare landscape in the U.A.E. has changed in significant ways, as new key entities launching and consolidating. Abu Dhabi Developmental Holding Company (ADQ), an investment management company that had a broad portfolio of important healthcare enterprises in Abu Dhabi such as Abu Dhabi Health Services Company (SEHA), continued its expansion into the healthcare space by launching Union 71, a laboratory testing company, and Rafed, a Group Purchasing Organization to manage and develop the procurement of healthcare-related services and products after the emergence of these two groups, ADQ signed an agreement merging both Rafed and Union71 with Pure Health, a key integrated healthcare solutions provider in the U.A.E.

UAE IVF Drugs and Food Supplements Market: Restraint

The higher cost of treatment as compared to other countries in the UAE is considered the major limiting factor for more patients coming from abroad. However, based on Colliers’s discussions with major providers in the UAE which states that the high success rates and quality are directly related to the significant investments made in this sector both in equipment and staff. If treatment fees for IVF are substantially reduced, it will have an impact on the UAE’s ability to retain the IVF facilities.